A proprietary chemistry platform from the laboratory of Dr. Andrei Yudin at the University of Toronto allows efficient synthesis of uniquely substituted ring systems comprising six to twenty or more contiguous atoms. Our core Discovery capability focuses on the design of molecules that address emerging principles in the chemical space required to mediate protein-protein interactions. The company's collaborative programs reflect the evolving understanding in this space and in the identification of key drug targets.
Company Details
- Founded
- 2012
- Address
- Emerging Principles In The Chemical Space Required To Mediate Protein-Protein Interactions. The Company's Collaborative Programs Reflect The Evolving Understanding In This Space And In The Identification Of Key Drug Targets.
- Phone
- (647) 258-4500
- jc****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- encycletherapeutics.com
- Keywords
- Mississauga.
Encycle Therapeutics Questions
Encycle Therapeutics's helpline number is (647) 258-4500
Encycle Therapeutics's website is encycletherapeutics.com
Encycle Therapeutics's LinkedIn profile is https://ca.linkedin.com/company/encycle-therapeutics-inc
Encycle Therapeutics's industry is
Biotechnology Research
Encycle Therapeutics's top competitors are
Regenesis Biotech,
Mymindbodybaby Inc.,
Toronto Research Chemicals,
Syninnova Laboratories Inc,
Heros Biotech,
Tiap - Toronto Innovation Acceleration Partners,
Sixth Wave Innovations Inc.,
Grey Matter Neurosciences,
Radiology News,
Nuvate.
Encycle Therapeutics's support email address is jcoull@encycletherapeutics.com
Encycle Therapeutics's categories are Biotechnology Research
Encycle Therapeutics's founding year is 2012
